Merrimack Pharmaceuticals Overview

  • Founded
  • 1993
Founded
  • Status
  • Public
  • Employees
  • 27
Employees
  • Stock Symbol
  • MACK
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $3.37
  • (As of Thursday Closing)

Merrimack Pharmaceuticals General Information

Description

Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • One Kendall Square
  • Suite B7201
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Merrimack Pharmaceuticals Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.37 $3.22 $1.49 - $7.09 $45.1M 13.4M 25.8K -$0.50

Merrimack Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 26,531 21,235 (18,591) 79,302
Revenue 0 0 0 0
EBITDA (4,018) (19,761) (64,731) (79,427)
Net Income 1,642 (17,332) (40,506) 472,028
Total Assets 19,681 20,082 88,543 117,326
Total Debt 0 0 14,873 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Merrimack Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merrimack Pharmaceuticals‘s full profile, request access.

Request a free trial

Merrimack Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicin
Drug Delivery
Cambridge, MA
27 As of 2018
00000
0000 0000-00-00
00000000 00000

0000000

mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
0000 000000000
Cambridge, MA
00 As of 0000
00000
000000000 00000

0000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000 000000000
Heidelberg, Germany
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merrimack Pharmaceuticals Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genocea Biosciences Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Heidelberg, Germany 000 00000 00000000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000 00000000(00000 Corporate Backed or Acquired Cambridge, MA 000 000.00 00000000 000.00
You’re viewing 5 of 29 competitors. Get the full list »

Merrimack Pharmaceuticals Executive Team (14)

Name Title Board Seat Contact Info
Khalid Mamlouk Vice President, Head Medical Affairs
Gary Crocker Chief Executive Officer & Chief Financial Officer, Finance
You’re viewing 2 of 14 executive team members. Get the full list »

Merrimack Pharmaceuticals Board Members (12)

Name Representing Role Since
James Dresser Self Board Member 000 0000
James Quigley Self Board Member 000 0000
Russell Ray Merrimack Pharmaceuticals Board Member 000 0000
Ulrik Nielsen Ph.D Merrimack Pharmaceuticals Board Member 000 0000
You’re viewing 4 of 12 board members. Get the full list »

Merrimack Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merrimack Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 07-Dec-2009 000000000000000000 00.00 Drug Delivery
To view Merrimack Pharmaceuticals’s complete acquisitions history, request access »